STAT+: The unexpected alliance lobbying for Medicare to pay for new obesity drugs
WASHINGTON — It’s not every day that the pharmaceutical industry, the NAACP, a cancer center, and…
Category: access
Opinion: Reinventing health care in 2023
After a year defined by record inflation and double-digit health care premium increases, I hope…
Opinion: Specialized centers can help realign the U.S.’s moral compass for sickle cell disease
Even as the United States has made commitments to health as a human right and…
Opinion: Hospitals need to make their websites as accessible as their physical spaces
It would be anathema for a health care facility in the U.S. to have a…
STAT+: Dozens of institutional investors urge drugmakers to link executive compensation to access to medicines
Three dozen institutional investors are urging the boards at several of the world’s largest pharmaceutical…
STAT+: ‘Patchy efforts’ by major insulin makers mean access lags in many poor countries
The three companies that dominate the global market for insulin have launched various programs to…
White House’s open-access research directive scrambles long-entrenched models, raising key questions
In August, the White House’s Office of Science and Technology Policy released a memo directing…
Opinion: The Inflation Reduction Act will help the U.S. achieve maximum vaccine access and uptake, but access gaps remain
One of the many achievements in the Inflation Reduction Act (IRA), which President Biden signed…